Schering-Plough Now in the Feds' CrosshairsThe Great Disappointment of EthicsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and...
How Pharma Stacks the Deck with Medical JournalsStatistical GymnasticsPublished on www.brainblogger.com:A Failed Attempt to Improve Misperceived Greatness: The ENHANCE TrialWhile it seems that pharmaceutical company sponsors of clinical trials usually end up with results that clearly favor their meds studied in their trial, there are rare exceptions, and Merck...
GlaxoSmithKline's GSK cervical cancer vaccine, Cervarix, may have the edge over US rival Merck's product Gardasil, according to trial results presented this week in America. GlaxoSmithKline's GSK cervical cancer vaccine, Cervarix, may have the edge over US rival Merck's product Gardasil, according...
Despite damaging results from a recent clinical trial on Merck's popular heart medication Zocor, the percentage of negative discussion posts about the drug by thousands of highly engaged consumers across dozens of leading cardiovascular Web sites has actually decreased 45 percent in the two weeks following the trial results. According...
Elitra Collaborates With Merck to Develop Antibiotics A Genetronics Biomedical Corp. spokesman said the biotechnology firm hopes to raise between $2 million and $3 million from private investors by the year's end. The private placement follows r Elitra Collaborates With Merck...
* Participating in a trial can provide you with the newest treatments and drugs for everything from allergies to cancer; in some cases, you get paid too. "These studies gather data on the safety or efficacy of medical treatments or drugs before they're released to the public," says Annice Bergeris,...
Former IFBB pro bodybuilder Craig Titus pleaded guilty to second degree murder first degree kidnapping and first degree arson on May 30, and his wife former IFBB fitness pro Kelly Ryan admitted to arson and entered an Alford plea to the charge of battery with use of deadly weapon resulting...
Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE: SSS) today announced its financial results for the period ended June 30, 2008. Selected Highlights During the second quarter of 2008 and up to August 27, 2008, SCT achieved the following accomplishments: - On April 23, 2008, SCT announced that the U.S. Food...
FORT WORTH, Texas, Aug. 26 /PRNewswire/ -- Healthpoint today announced that it has initiated a clinical trial to evaluate the effectiveness of a widely prescribed enzymatic debriding agent on healing cutaneous wounds and resulting scars. The pilot study was prompted, in part, by clinical reports of the reduced incidence...
- Results in Proceeds of $2.0 Million - MONTVALE, N.J., Aug. 26 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that it has secured $2.0 million through the sale of approximately 4.7 million shares of common stock at $0.42 per share under its June 2007 equity financing...
VLP Vaccine - Coupled with Innovative Manufacturing - Has Potential to Address Gaps in Global Pandemic Preparedness ROCKVILLE, Md., Aug. 26 /PRNewswire-FirstCall/ -- Novavax, Inc. announced today favorable results from the second stage of the Phase I/IIa human clinical trial of its pandemic influenza virus-like particle...
SEATTLE, Aug. 26 /PRNewswire/ -- Omeros Corporation today announced the publication of the results from a Phase 1/Phase 2 trial investigating OMS103HP in arthroscopic anterior cruciate ligament ACL reconstruction surgery. OMS103HP is an investigational drug product that is added to arthroscopic irrigation solution and is designed to improve postoperative...
VELOCITY Trial Published in Annals of Emergency Medicine PARSIPPANY, N.J. -- The Medicines Company (NASDAQ: MDCO) today announced that the results of VELOCITY, a pivotal Phase 3 safety and efficacy trial of its new intravenous IV therapy Cleviprex[TM] clevidipine butyrate injectable emulsion, were published in the August issue...
With food safety top of mind for consumers and the food industry, Vacci-Test Corporation ("Vacci-Test") is pleased to announce that its first food safety test, FoodChekTM-E.coli, has successfully completed a field trial at a major meat packaging facility and has shown that it can accurately test for E.coli O157:H7 in...
Results Presented at 12th Congress of European Federation of Neurological Societies JERUSALEM -- Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announces that results of the phase III ADAGIO trial were presented today during the 12th Congress of European Federation of Neurological Societies EFNS in Madrid, Spain as part of...
ProTrials Selected as One of the Fastest-Growing Private Companies in the U.S. MOUNTAIN VIEW, Calif. -- ProTrials Research, Inc.TM, a leader in the clinical research organization industry, today announced the company made the 2008 Inc. 5000 list of the fastest-growing private companies in the United States. With 125...
SAN ANTONIO -- A production beta version of a compressor plate valve developed at Southwest Research Institute is demonstrating long operating life in real-time field conditions. The SwRI Semi-Active Compressor Valve, developed in 2006, is currently installed in a high-speed compressor at a natural gas production site for a long-term...
WSI Fusion selected by the majority of airlines participating in the EUROCONTROL EFD trial BIRMINGHAM, U.K. -- WSI today announced that a majority of the airlines participating in EUROCONTROL's Electronic Flight Data EFD trial are utilizing WSI Fusion in order to depict aircraft positions via the radar situational...
Company Receives Approval from Chinese Health Authorities to Launch Final Clinical Trial for AsacardR NEW HAVEN, Conn., Aug. 25 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced the appointment of Dr. Geert Cauwenbergh as Chief Executive Officer. Dr. Cauwenbergh succeeds Joos Horsten, who recently passed away. Dr...
WYOMISSING, Pa. -- Carpenter Technology Corporation (NYSE:CRS) today announced that, as a result of a recent trial court ruling related to environmental activities from more than 30 years ago, the special litigation reserve previously reported as part of its results for the fourth quarter of its 2008 fiscal year has...